Aortic Stenosis Clinical Trial
Official title:
The Effects of High Spinal Anesthesia on Hemodynamics, Stress Response, Renal Function and Post-operative Pain Control in Patients Undergoing Aortic Valve Replacement for Aortic Stenosis
This study is looking at the effects of high spinal anesthesia (also known as total spinal
anesthesia) combined with general anesthesia versus general anesthesia alone on the
following:
Stress response: Patients undergoing aortic valve replacement surgery have a large incision
and a complex operation where they must be placed on the heart-lung machine. The body reacts
to the heart-lung machine, increasing the stress response.
High spinal anesthesia using local anesthetics when combined with general anesthesia has
been shown to block some of the stress response to surgery and the response to the
heart-lung machine. This study will examine if blood levels of stress hormones and also
inflammatory mediators can be lowered with the use of high spinal anesthesia.
Heart function: High spinal anesthesia in combination with general anesthesia may help the
heart work better when there is a narrowed valve (aortic stenosis). The heart may also have
improved ability to pump blood with this anesthetic technique.
Lung function and post-operative pain control: After surgery, patients often have pain which
prevents them from taking deep breaths and coughing. This can lead to pneumonia. This study
will also examine if the post-operative pain relief provided by spinal morphine (given
together with the spinal anesthetic) can provide any better pain control following surgery.
By doing this, we want to see if patients can take bigger breaths after their surgery when
spinal morphine is used, and try to prevent the complications that occur if patients are not
able to breath deeply after surgery.
It is hypothesized that high spinal anesthesia combined with general anesthesia decreases
the intraoperative stress and inflammatory response and improve post-operative pain control
and respiratory function in this patient population. It is also hypothesized that the
technique will provide stable intraoperative hemodynamics during aortic valve replacement
surgery.
Stress response: Levels of hormones such as epinephrine, norepinephrine and cortisol are
elevated during cardiac surgery and on the initiation of cardiopulmonary bypass. This stress
response has previously been shown to be blunted with the use of high spinal anesthesia when
combined with general anesthesia in coronary artery bypass surgery patients (Lee, Grocott,
et al).
Inflammatory response: In addition to the stress response there is also an accentuated
inflammatory response. With contact of the patient's blood to the artificial bypass circuit,
there is activation of various plasma protease pathways that generate multiple
proinflammatory mediators. Complement levels and cytokine levels also rise. Clinical organ
dysfunction involving the cardiovascular, pulmonary, renal and neurological systems can
ultimately result. The effects of high spinal anesthesia on the inflammatory response that
occurs with bypass have not been studied.
Hemodynamics: It has previously been shown that high-spinal anesthesia for coronary artery
bypass surgery provides stable intra-operative hemodynamics (Kowalewski, MacAdams, et al;
Lee, Grocott, et al.). Although the use of spinal anesthesia in patients with aortic
stenosis has been considered to be relatively contra-indicated, total spinal anesthesia may
actually improve cardiac function by decreasing systemic afterload and increasing myocardial
contractility.
Post-operative analgesia and pulmonary function: The spinal administration of opioids, such
as morphine, has been shown to improve post-operative pain management in patients having
both cardiac and non-cardiac surgery (Jacobsohn, Lee, et al). Total spinal anesthesia with
bupivacaine and spinal morphine combined with general anesthesia may also improve
post-operative pain management and facilitate improved post-operative lung function.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04310046 -
Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial
|
N/A | |
Completed |
NCT03332745 -
Mechanism of Decompensation Evaluation - Aortic Stenosis
|
||
Recruiting |
NCT06008080 -
Post-Market Clinical Follow Up Study With Navitor Valve
|
||
Recruiting |
NCT06055751 -
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
|
||
Active, not recruiting |
NCT04815785 -
Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis
|
N/A | |
Terminated |
NCT02202434 -
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
|
N/A | |
Recruiting |
NCT03029026 -
The Role of Occult Cardiac Amyloid in the Elderly With Aortic Stenosis.
|
||
Active, not recruiting |
NCT02903420 -
A Clinical Trial of Transcatheter Aortic Valves in Dialysis Patients (Japan)
|
N/A | |
Completed |
NCT02629328 -
CardioCel Tri-leaflet Repair Study
|
N/A | |
Completed |
NCT02306226 -
Symetis ACURATE Neo™ Valve Implantation SAVI TF Registry
|
||
Withdrawn |
NCT01648309 -
Neuropsychological Testing in Patients Undergoing Transvascular Aortic Valve Implantation
|
N/A | |
Completed |
NCT01676727 -
ADVANCE Direct Aortic Study
|
||
Completed |
NCT01422044 -
Risk Prediction in Aortic Stenosis
|
N/A | |
Withdrawn |
NCT00774657 -
Ventricular Remodeling In Patients With Aortic Stenosis Assessed Echocardiography
|
N/A | |
Terminated |
NCT00535899 -
Speckle Tracking Imaging in Patients With Low Ejection Fraction Aortic Stenosis (SPArKLE-AS)
|
N/A | |
Terminated |
NCT05070130 -
OpSens PRIME CLASS
|
||
Completed |
NCT03314857 -
China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population
|
N/A | |
Completed |
NCT04157920 -
Impact of Predilatation Between Self-expanding Valves
|
N/A | |
Enrolling by invitation |
NCT06212050 -
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
|
||
Recruiting |
NCT05893082 -
Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
|
N/A |